What does clean technology mean to you? Do you have an innovative idea about using technology in natural resource sectors?
Share your thoughts on what Canada could do to work towards cleaner energy in the future.
Cubresa's new patent in the US for flexible imagine sensors allows for 3D imaging of traditionally difficult to image areas for cancer detection in humans and animals.
Valeant Canada announced an $8 million investment into its Steinbach, Manitoba manufacturing plant for Xifaxan and Apriso.
The 2016 Provincial budget increases funding to support the provision of cancer drugs for patients across the province by $4 million.
The awards were presented May 19, 2016 at Rideau Hall in Ottawa
Drs Foerster and Torchia will be inducted as the 3rd and 4th members of the Hall of Fame.
The St. Boniface Hospital’s RBC Youth BIOlab Jeunesse will receive $120,000 over 3 years from the Natural Sciences and Engineering Research Council of Canada (NSERC) ensuring that today's youth are engaged in science from an early age your years to come.
Cubresa Inc. today, announced the release of its NuPET™ scanner.
NAUGURAL AWARD RECOGNIZES ENTREPRENEURIAL INNOVATION
Kane Biotech Inc. is pleased to announce that it has received a breakthrough order of its bluestem™ brand of oral care products from a major North American pet specialty store chain.
The Government of Canada is investing over $165 million in the Youth Employment Strategy (YES) starting this year through Budget 2016.
Dr Grant Pierce, Executive Director of Research, St-Boniface Hospital is pleased to announce the appointment of Dr Carla Taylor as Team Leader of the Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), for a 3 year term.
For the second time in three years, Winnipeg has earned a coveted spot on the Intelligent Community Forum’s (ICF) list of the Top7 Intelligent Communities in the world.
Rather than take the conventional route of achieving regulatory approval in Canada and the U.S. and then exporting the technology elsewhere around the world, ASI is going to China first.
Company completing Phase 1 human clinical trial of drug to prevent dermal scarring
To date, four Canadians have returned from travels testing positive for the Zika virus and the pressure is on to develop a vaccine in case the mosquito-borne virus develops into a global emergency, says Dr. Gary Kobinger, chief of special pathogens with t
Audrey Goertzen CPA, CGA will be Kane Biotech’s new CFO, replacing Mark Matthewson CPA, CA.
On December 1, 2015, the Human Pathogens and Toxins ActExternal Link (HPTA) came into full force.
Launching Start-Up Central District.
Cubresa Inc., which has a device ready to go to market, just closed a $3.5-million financing deal and hired a Boston-based CEO who's plugged into Cubresa's specialty market.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.